Analyze & Realize
Analyze & Realize is a Berlin-based B2B consultancy and clinical research provider serving natural health product manufacturers across food supplements, OTC drugs, medical devices, cosmetics, and herbal medicinal products in Europe, with regulatory consulting, clinical trials, and licensing matchmaking services.
- Company typePrivate
- Founded2000
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Analyze & Realize does
Analyze & Realize GmbH (a&r) is a Berlin-based B2B consultancy and clinical research provider specializing in natural health products within the consumer healthcare space. Founded in 2000/2001 as a privately held German GmbH, the firm serves manufacturers and distributors of food and dietary supplements, OTC drug products, substance-based medical devices, cosmetics, and traditional herbal medicinal products across EMEA. The company operates as part of the Biofortis Group together with Biofortis CRO and QUALILAB, providing an integrated offering across Clinical Research, Regulatory Affairs, and Quality Management.
The company's service portfolio spans four lines: Regulatory Consulting (market assessments, EU dossier compilation, novel food applications under (EU) 2015/2283, health claims substantiation, MDR compliance); Strategic Innovation & Consulting (innovation strategy, market analysis, scientific and regulatory affairs); Clinical Research (highly customized study designs, study center operations, clinical research consulting); and Digital Trials (a proprietary workflow automation platform for technology-enabled clinical study conduct). Additionally, the a&r MatchMaking Platform, launched in 2017, connects companies seeking in/out-licensing opportunities for premium finished products, branded ingredients, and technologies in the natural health products sector.
Revenue is generated through professional-services engagements (regulatory and clinical consulting, strategic advisory) and platform-based licensing/matchmaking services. The company goes to market primarily via direct enterprise sales supplemented by thought-leadership channels — webinars, industry conferences (notably Vitafoods Europe), a monthly newsletter, and active social media presence on LinkedIn and X. Crédit d'Impôt Recherche (CIR) accreditation by the French Ministry of Research supports French enterprise deal flow, and the firm maintains memberships in NCN Nutrition Capital Networks, BVMA, and Lebensmittelverband. Leadership includes Managing Director Cédric Lingfeld (appointed 2024), co-Managing Director Dr. Volker Schehlmann, Director Consulting & Strategic Innovation Dr. Heike Stier, and Founder Joerg Gruenwald as Chief Scientific Advisor; headcount is reported at 11–50.
Analyze & Realize firmographics
Firmographics- Name
- Analyze & Realize
- Legal name
- analyze & realize GmbH
- Website
- https://a-r.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Analyze & Realize is a Berlin-based B2B consultancy and clinical research provider serving natural health product manufacturers across food supplements, OTC drugs, medical devices, cosmetics, and herbal medicinal products in Europe, with regulatory consulting, clinical trials, and licensing matchmaking services.
- Ownership category
- akta.pro rank
Analyze & Realize industry classification
Industry- Product category
- Natural Health Products Consulting & Clinical Research
- NAICS
- Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)
- SIC
- Services-Management Consulting Services (8742), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
- akta.pro secondary industries
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)
Keywords
Where Analyze & Realize is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Analyze & Realize business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Regulatory Consulting Services: Professional consulting services for natural health products including market assessments, dossier compilation for European market compliance, product conception to market entry support, and regulatory affairs guidance.
- Clinical Research Services: Clinical trial design, execution, and consulting services covering broad range of clinical trial types and indications. Services include study center operations and clinical research consulting.
- Strategic Innovation & Market Analysis: Strategic consulting services including innovation strategy design, market analysis, and support from scientific and regulatory affairs through market entry.
- Licensing & Matchmaking Services: Platform-based matchmaking services for licensing opportunities in natural health products, including technology and product scouting, due diligence, competitive intelligence, and market analysis.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
Analyze & Realize product offering
Product offeringCore offering
Analyze & Realize is a Berlin-based consultancy and clinical research provider that helps manufacturers and distributors of natural health products navigate European regulatory frameworks and bring products to market. Its core offerings include regulatory consulting (food supplements, OTC drugs, medical devices, cosmetics), strategic innovation and market analysis consulting, and customized clinical research services supported by a proprietary Digital Trials platform and the a&r MatchMaking Platform for in/out-licensing opportunities.
Product overview
Analyze & Realize GmbH is a leading consultancy and clinical research provider specializing in natural health products within the consumer healthcare space. With over two decades of experience, the company offers a unified portfolio of regulatory consulting (covering food supplements, OTC drugs, medical devices, and cosmetics), strategic innovation and consulting services, clinical research capabilities (including clinical trials, study center operations, and clinical research consulting), and a Digital Trials platform. The company also operates an a&r MatchMaking Platform for licensing opportunities. Their integrated approach combines scientific, regulatory, and clinical expertise to support clients from product conception through market entry in Europe.
Differentiator
Problem solved
Functional benefit
Brands
- a&r MatchMaking Platform: Licensing and matchmaking platform launched in 2017 for in/out-licensing opportunities in natural health products, featuring premium finished products, branded ingredients, and other technologies
Products and services
- Regulatory Consulting Services Expert regulatory support for manufacturers and distributors of natural health products (food supplements, OTC drug products, medical devices, cosmetics), covering market assessments, dossier compilation for European market compliance, and support from product conception through market entry for national and international clients.
- Strategic Innovation & Consulting Strategic consulting services supporting the design and implementation of innovation strategies in target markets for national and international clients in the Life Science market, extending from scientific and regulatory affairs through market entry.
- Clinical Research Services Clinical research services providing highly customized study designs covering a broad range of clinical trial types and indications, with full alignment of scientific validity, regulatory requirements and business needs, including study center operations and clinical research consulting.
- Digital Trials Digital trials platform enabling technology-enabled clinical study conduct with key features, workflow automation and documented case studies for natural health product research.
- a&r MatchMaking Platform Licensing platform launched in 2017 that brings together companies looking for local and worldwide in/out-licensing opportunities in natural health products, featuring premium finished products, branded ingredients and other technologies in its licensing database.
- Market Analysis Services Market analysis and competitive intelligence services supporting strategic decision-making for clients in the natural health products sector, including technology and product scouting and due diligence.
Quantifiable outcome
- EFSA panel confirmed clinical studies conducted by a&r showed the claimed effect in health claim application process
- +2 more outcomes
Companies that use Analyze & Realize
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles2 records
Analyze & Realize technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Analyze & Realize partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Biofortis GroupcoreAnalyze & Realize is part of Biofortis Group, which includes Biofortis CRO and QUALILAB. The group provides integrated expertise in Clinical Research, Regulatory Affairs, and Quality Management for the nutraceutical industry. Companies from the group will exhibit together at Vitafoods Europe 2026.
- QUALILABminorPart of Biofortis Group, providing quality management services alongside a&r's regulatory and clinical research expertise.
- Biofortis CROminorPart of Biofortis Group, providing clinical research organization services.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Analyze & Realize competitors and assessment
Company assessmentDirect peers
- NSF International: Global public health and safety organization providing testing, certification, and consulting for dietary supplements and natural health products. Comparable to a&r in regulatory and quality services for the nutraceutical industry, with similar B2B customer base.
- Pharmalex: European regulatory affairs and pharmacovigilance consultancy serving pharma, biotech, and consumer health. Comparable to a&r in providing regulatory consulting and clinical/regulatory affairs services to life sciences companies across EU markets.
- Mérieux NutriSciences (Institut Mérieux): Specialized food and nutrition testing, consulting, and clinical research provider. One of the closest direct comparables to a&r given its focus on food supplements, nutraceuticals, and clinical safety/efficacy studies, with a strong European footprint.
- Biofortis CRO: Sister company within the Biofortis Group providing clinical research organization services for nutraceuticals. Direct peer given shared group ownership, similar B2B customer base, and overlapping clinical research service offerings in natural health products.
Broad incumbents
- SGS SA: Global testing, inspection, and certification company with health and nutrition services. Comparable to a&r in providing quality/safety testing and clinical research support for food supplements and natural health products, but at much larger scale.
- Eurofins Scientific: Global testing and CRO services giant with food/feed and pharmaceutical testing capabilities. Comparable to a&r as both serve nutraceutical and natural health product companies with laboratory and regulatory support, though Eurofins is far broader and operates at much larger scale.
- ICON plc: Global clinical research organization providing clinical trial and consulting services. Comparable to a&r in clinical research delivery for regulated health products, though ICON is a large multi-therapeutic area incumbent.
- Intertek Group: Global testing and quality assurance provider with food and health product services. Comparable to a&r in supporting food supplement and natural health product companies with testing, certification, and regulatory-adjacent services, though Intertek is a large diversified incumbent.
- IQVIA: Global CRO and life sciences services leader. Comparable to a&r in clinical research services for healthcare products, though IQVIA operates at far larger scale and is primarily pharma-focused; it has been expanding into consumer health adjacencies.
Others
- dsm-firmenich (i-Health / Health & Nutrition): Major ingredient and health nutrition company investing in clinical substantiation and regulatory services for nutraceuticals. Comparable to a&r as a strategic partner/customer in the natural health product value chain, not a direct services competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Analyze & Realize social profiles
Digital presenceAnalyze & Realize financial estimates
Financial estimateRevenue estimate
Valuation estimate
Analyze & Realize leadership team
Management profileNumber of profiles
Profiles6 records
Analyze & Realize subsidiaries and ownership
Company hierarchySubsidiaries2 records
Analyze & Realize funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Analyze & Realize M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Analyze & Realize
What does Analyze & Realize do?
Analyze & Realize is a Berlin-based consultancy and clinical research provider that helps manufacturers and distributors of natural health products navigate European regulatory frameworks and bring products to market. Its core offerings include regulatory consulting (food supplements, OTC drugs, medical devices, cosmetics), strategic innovation and market analysis consulting, and customized clinical research services supported by a proprietary Digital Trials platform and the a&r MatchMaking Platform for in/out-licensing opportunities.
Is Analyze & Realize a public or private company?
Analyze & Realize is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Analyze & Realize founded?
Analyze & Realize was founded in 2000. It employs 11 to 50 people.
Where is Analyze & Realize based?
Analyze & Realize is headquartered in Berlin, Germany, in the Europe region.
How does Analyze & Realize make money?
Four revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are clinical Research Services, strategic Innovation & Market Analysis and licensing & Matchmaking Services.
Who are Analyze & Realize's main competitors?
Direct peers on record are NSF International, Pharmalex, Mérieux NutriSciences (Institut Mérieux) and Biofortis CRO. Broad incumbents are SGS SA, Eurofins Scientific, ICON plc, Intertek Group and IQVIA. dsm-firmenich (i-Health / Health & Nutrition) is listed as an others.
Does Analyze & Realize have an API?
No public API is recorded for Analyze & Realize.
What industry is Analyze & Realize in?
Analyze & Realize's product category is Natural Health Products Consulting & Clinical Research. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics. Its NAICS code is 54169 and its SIC code is 8742.